APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Retinoids

Compare research editions
View pricing & licenses

Selected research

Industry Research

Topical Retinoids Industry Research Report 2026

28 December 2025142 pages

Choose your research edition.

Industry ResearchTopical Retinoids Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Retinoids Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Topical Retinoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Retinoids Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Retinoids Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Topical Retinoids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Topical Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Topical Retinoids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Topical Retinoids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Topical Retinoids include Chongqing Huapont Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Shanghai Sine Pharmaceutical, Shanghai Shyndec Pharmaceutical, Kangzheng pharmaceutical, Hubei Hengan Fulin Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, HEC Pharm and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Topical Retinoids market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Topical Retinoids Market by Company

Chongqing Huapont Pharmaceutical

Sichuan Med-Shine Pharmaceutical

Shanghai Sine Pharmaceutical

Shanghai Shyndec Pharmaceutical

Kangzheng pharmaceutical

Hubei Hengan Fulin Pharmaceutical

Heilongjiang Fuhe Pharmaceutical

HEC Pharm

Teva

Taro Pharmaceutical

Sandoz

Padagis

Ligand Pharmaceuticals

Hikma

Galderma Laboratories

Eisai

Dr. Reddy's Laboratories

Bionpharma

Bausch Health

Amneal Pharmaceuticals

Amdipharm

Allergan

Alembic

Actavis

Topical Retinoids Segment by Type

Gel

Cream

Lotion

Others

Topical Retinoids Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Topical Retinoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Retinoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Retinoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Retinoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Topical Retinoids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Topical Retinoids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Topical Retinoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Topical Retinoids Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Topical Retinoids Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Topical Retinoids Sales Market Share by Manufacturers (2021-2026) Table 8. Global Topical Retinoids Revenue of Manufacturers (2021-2026) Table 9. Global Topical Retinoids Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Topical Retinoids Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Topical Retinoids Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Topical Retinoids, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Topical Retinoids, Product Type & Application Table 14. Global Topical Retinoids Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Topical Retinoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Huapont Pharmaceutical Company Information Table 19. Chongqing Huapont Pharmaceutical Business Overview Table 20. Chongqing Huapont Pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Huapont Pharmaceutical Topical Retinoids Product Portfolio Table 22. Chongqing Huapont Pharmaceutical Recent Developments Table 23. Sichuan Med-Shine Pharmaceutical Company Information Table 24. Sichuan Med-Shine Pharmaceutical Business Overview Table 25. Sichuan Med-Shine Pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sichuan Med-Shine Pharmaceutical Topical Retinoids Product Portfolio Table 27. Sichuan Med-Shine Pharmaceutical Recent Developments Table 28. Shanghai Sine Pharmaceutical Company Information Table 29. Shanghai Sine Pharmaceutical Business Overview Table 30. Shanghai Sine Pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shanghai Sine Pharmaceutical Topical Retinoids Product Portfolio Table 32. Shanghai Sine Pharmaceutical Recent Developments Table 33. Shanghai Shyndec Pharmaceutical Company Information Table 34. Shanghai Shyndec Pharmaceutical Business Overview Table 35. Shanghai Shyndec Pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shanghai Shyndec Pharmaceutical Topical Retinoids Product Portfolio Table 37. Shanghai Shyndec Pharmaceutical Recent Developments Table 38. Kangzheng pharmaceutical Company Information Table 39. Kangzheng pharmaceutical Business Overview Table 40. Kangzheng pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Kangzheng pharmaceutical Topical Retinoids Product Portfolio Table 42. Kangzheng pharmaceutical Recent Developments Table 43. Hubei Hengan Fulin Pharmaceutical Company Information Table 44. Hubei Hengan Fulin Pharmaceutical Business Overview Table 45. Hubei Hengan Fulin Pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hubei Hengan Fulin Pharmaceutical Topical Retinoids Product Portfolio Table 47. Hubei Hengan Fulin Pharmaceutical Recent Developments Table 48. Heilongjiang Fuhe Pharmaceutical Company Information Table 49. Heilongjiang Fuhe Pharmaceutical Business Overview Table 50. Heilongjiang Fuhe Pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Heilongjiang Fuhe Pharmaceutical Topical Retinoids Product Portfolio Table 52. Heilongjiang Fuhe Pharmaceutical Recent Developments Table 53. HEC Pharm Company Information Table 54. HEC Pharm Business Overview Table 55. HEC Pharm Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. HEC Pharm Topical Retinoids Product Portfolio Table 57. HEC Pharm Recent Developments Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Teva Topical Retinoids Product Portfolio Table 62. Teva Recent Developments Table 63. Taro Pharmaceutical Company Information Table 64. Taro Pharmaceutical Business Overview Table 65. Taro Pharmaceutical Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Taro Pharmaceutical Topical Retinoids Product Portfolio Table 67. Taro Pharmaceutical Recent Developments Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sandoz Topical Retinoids Product Portfolio Table 72. Sandoz Recent Developments Table 73. Padagis Company Information Table 74. Padagis Business Overview Table 75. Padagis Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Padagis Topical Retinoids Product Portfolio Table 77. Padagis Recent Developments Table 78. Ligand Pharmaceuticals Company Information Table 79. Ligand Pharmaceuticals Business Overview Table 80. Ligand Pharmaceuticals Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Ligand Pharmaceuticals Topical Retinoids Product Portfolio Table 82. Ligand Pharmaceuticals Recent Developments Table 83. Hikma Company Information Table 84. Hikma Business Overview Table 85. Hikma Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hikma Topical Retinoids Product Portfolio Table 87. Hikma Recent Developments Table 88. Galderma Laboratories Company Information Table 89. Galderma Laboratories Business Overview Table 90. Galderma Laboratories Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Galderma Laboratories Topical Retinoids Product Portfolio Table 92. Galderma Laboratories Recent Developments Table 93. Eisai Company Information Table 94. Eisai Business Overview Table 95. Eisai Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Eisai Topical Retinoids Product Portfolio Table 97. Eisai Recent Developments Table 98. Dr. Reddy's Laboratories Company Information Table 99. Dr. Reddy's Laboratories Business Overview Table 100. Dr. Reddy's Laboratories Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Laboratories Topical Retinoids Product Portfolio Table 102. Dr. Reddy's Laboratories Recent Developments Table 103. Bionpharma Company Information Table 104. Bionpharma Business Overview Table 105. Bionpharma Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bionpharma Topical Retinoids Product Portfolio Table 107. Bionpharma Recent Developments Table 108. Bausch Health Company Information Table 109. Bausch Health Business Overview Table 110. Bausch Health Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bausch Health Topical Retinoids Product Portfolio Table 112. Bausch Health Recent Developments Table 113. Amneal Pharmaceuticals Company Information Table 114. Amneal Pharmaceuticals Business Overview Table 115. Amneal Pharmaceuticals Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Amneal Pharmaceuticals Topical Retinoids Product Portfolio Table 117. Amneal Pharmaceuticals Recent Developments Table 118. Amdipharm Company Information Table 119. Amdipharm Business Overview Table 120. Amdipharm Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Amdipharm Topical Retinoids Product Portfolio Table 122. Amdipharm Recent Developments Table 123. Allergan Company Information Table 124. Allergan Business Overview Table 125. Allergan Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Allergan Topical Retinoids Product Portfolio Table 127. Allergan Recent Developments Table 128. Alembic Company Information Table 129. Alembic Business Overview Table 130. Alembic Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Alembic Topical Retinoids Product Portfolio Table 132. Alembic Recent Developments Table 133. Actavis Company Information Table 134. Actavis Business Overview Table 135. Actavis Topical Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Actavis Topical Retinoids Product Portfolio Table 137. Actavis Recent Developments Table 138. Global Topical Retinoids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Topical Retinoids Sales by Region (2021-2026) & (K Units) Table 140. Global Topical Retinoids Sales Market Share by Region (2021-2026) Table 141. Global Topical Retinoids Sales by Region (2027-2032) & (K Units) Table 142. Global Topical Retinoids Sales Market Share by Region (2027-2032) Table 143. Global Topical Retinoids Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Topical Retinoids Revenue Market Share by Region (2021-2026) Table 145. Global Topical Retinoids Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Topical Retinoids Revenue Market Share by Region (2027-2032) Table 147. North America Topical Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 149. North America Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 150. North America Topical Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Topical Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Topical Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 154. Europe Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 155. Europe Topical Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Topical Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Topical Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 159. Asia Pacific Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 160. Asia Pacific Topical Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Topical Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Topical Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 164. South America Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 165. South America Topical Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Topical Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Topical Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Topical Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Topical Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Topical Retinoids Sales by Type (2021-2026) & (K Units) Table 173. Global Topical Retinoids Sales by Type (2027-2032) & (K Units) Table 174. Global Topical Retinoids Sales Market Share by Type (2021-2026) Table 175. Global Topical Retinoids Sales Market Share by Type (2027-2032) Table 176. Global Topical Retinoids Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Topical Retinoids Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Topical Retinoids Revenue Market Share by Type (2021-2026) Table 179. Global Topical Retinoids Revenue Market Share by Type (2027-2032) Table 180. Global Topical Retinoids Price by Type (2021-2026) & (US$/Unit) Table 181. Global Topical Retinoids Price by Type (2027-2032) & (US$/Unit) Table 182. Global Topical Retinoids Sales by Application (2021-2026) & (K Units) Table 183. Global Topical Retinoids Sales by Application (2027-2032) & (K Units) Table 184. Global Topical Retinoids Sales Market Share by Application (2021-2026) Table 185. Global Topical Retinoids Sales Market Share by Application (2027-2032) Table 186. Global Topical Retinoids Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Topical Retinoids Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Topical Retinoids Revenue Market Share by Application (2021-2026) Table 189. Global Topical Retinoids Revenue Market Share by Application (2027-2032) Table 190. Global Topical Retinoids Price by Application (2021-2026) & (US$/Unit) Table 191. Global Topical Retinoids Price by Application (2027-2032) & (US$/Unit) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Topical Retinoids Distributors List Table 195. Topical Retinoids Customers List Table 196. Topical Retinoids Industry Trends Table 197. Topical Retinoids Industry Drivers Table 198. Topical Retinoids Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Topical Retinoids Product Image Figure 5. Global Topical Retinoids Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Topical Retinoids Market Size (2021-2032) & (US$ Million) Figure 7. Global Topical Retinoids Sales (2021-2032) & (K Units) Figure 8. Global Topical Retinoids Average Price (US$/Unit) & (2021-2032) Figure 9. Gel Product Image Figure 10. Cream Product Image Figure 11. Lotion Product Image Figure 12. Others Product Image Figure 13. Retail Pharmacy Product Image Figure 14. Online Pharmacy Product Image Figure 15. Hospital Pharmacy Product Image Figure 16. Global Topical Retinoids Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Topical Retinoids, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Topical Retinoids Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Topical Retinoids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Topical Retinoids Sales by Region in 2025 Figure 22. Global Topical Retinoids Revenue by Region in 2025 Figure 23. North America Topical Retinoids Market Size by Country in 2025 Figure 24. North America Topical Retinoids Sales Market Share by Country (2021-2032) Figure 25. North America Topical Retinoids Revenue Market Share by Country (2021-2032) Figure 26. United States Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Topical Retinoids Market Size by Country in 2025 Figure 30. Europe Topical Retinoids Sales Market Share by Country (2021-2032) Figure 31. Europe Topical Retinoids Revenue Market Share by Country (2021-2032) Figure 32. Germany Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Topical Retinoids Market Size by Country in 2025 Figure 43. Asia Pacific Topical Retinoids Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Topical Retinoids Revenue Market Share by Country (2021-2032) Figure 45. China Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Topical Retinoids Market Size by Country in 2025 Figure 54. South America Topical Retinoids Sales Market Share by Country (2021-2032) Figure 55. South America Topical Retinoids Revenue Market Share by Country (2021-2032) Figure 56. Brazil Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Topical Retinoids Market Size by Country in 2025 Figure 60. Middle East and Africa Topical Retinoids Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Topical Retinoids Revenue Market Share by Country (2021-2032) Figure 62. Egypt Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Topical Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Topical Retinoids Sales Market Share by Type (2021-2032) Figure 68. Global Topical Retinoids Revenue Market Share by Type (2021-2032) Figure 69. Global Topical Retinoids Price (US$/Unit) by Type (2021-2032) Figure 70. Global Topical Retinoids Sales Market Share by Application (2021-2032) Figure 71. Global Topical Retinoids Revenue Market Share by Application (2021-2032) Figure 72. Global Topical Retinoids Price (US$/Unit) by Application (2021-2032) Figure 73. Topical Retinoids Value Chain Figure 74. Topical Retinoids Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Topical Retinoids Industry Opportunities and Challenges

Scope & coverage.

Types
  • Gel
  • Cream
  • Lotion
  • Others
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Sichuan Med-Shine Pharmaceutical
  • Shanghai Sine Pharmaceutical
  • Shanghai Shyndec Pharmaceutical
  • Kangzheng pharmaceutical
  • Hubei Hengan Fulin Pharmaceutical
  • Heilongjiang Fuhe Pharmaceutical
  • HEC Pharm
  • Teva
  • Taro Pharmaceutical
  • Sandoz
  • Padagis
  • Ligand Pharmaceuticals
  • Hikma
  • Galderma Laboratories
  • Eisai
  • Dr. Reddy's Laboratories
  • Bionpharma
  • Bausch Health
  • Amneal Pharmaceuticals
  • Amdipharm
  • Allergan
  • Alembic
  • Actavis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Topical Retinoids Market Size (2021-2032)
  4. 2.2.2 Global Topical Retinoids Sales (2021-2032)
  5. 2.2.3 Global Topical Retinoids Market Average Price (2021-2032)
  6. 2.3 Topical Retinoids by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Gel
  9. 2.3.3 Cream
  10. 2.3.4 Lotion
  11. 2.3.5 Others
  12. 2.4 Topical Retinoids by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Retail Pharmacy
  15. 2.4.3 Online Pharmacy
  16. 2.4.4 Hospital Pharmacy
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Topical Retinoids Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Topical Retinoids Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Topical Retinoids Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Topical Retinoids Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Topical Retinoids Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Topical Retinoids, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Topical Retinoids, Product Type & Application
  8. 3.8 Global Manufacturers of Topical Retinoids, Established Date
  9. 3.9 Global Topical Retinoids Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Huapont Pharmaceutical
  2. 4.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 4.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 4.1.3 Chongqing Huapont Pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Huapont Pharmaceutical Topical Retinoids Product Portfolio
  6. 4.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 4.2 Sichuan Med-Shine Pharmaceutical
  8. 4.2.1 Sichuan Med-Shine Pharmaceutical Company Information
  9. 4.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
  10. 4.2.3 Sichuan Med-Shine Pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sichuan Med-Shine Pharmaceutical Topical Retinoids Product Portfolio
  12. 4.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  13. 4.3 Shanghai Sine Pharmaceutical
  14. 4.3.1 Shanghai Sine Pharmaceutical Company Information
  15. 4.3.2 Shanghai Sine Pharmaceutical Business Overview
  16. 4.3.3 Shanghai Sine Pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shanghai Sine Pharmaceutical Topical Retinoids Product Portfolio
  18. 4.3.5 Shanghai Sine Pharmaceutical Recent Developments
  19. 4.4 Shanghai Shyndec Pharmaceutical
  20. 4.4.1 Shanghai Shyndec Pharmaceutical Company Information
  21. 4.4.2 Shanghai Shyndec Pharmaceutical Business Overview
  22. 4.4.3 Shanghai Shyndec Pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai Shyndec Pharmaceutical Topical Retinoids Product Portfolio
  24. 4.4.5 Shanghai Shyndec Pharmaceutical Recent Developments
  25. 4.5 Kangzheng pharmaceutical
  26. 4.5.1 Kangzheng pharmaceutical Company Information
  27. 4.5.2 Kangzheng pharmaceutical Business Overview
  28. 4.5.3 Kangzheng pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Kangzheng pharmaceutical Topical Retinoids Product Portfolio
  30. 4.5.5 Kangzheng pharmaceutical Recent Developments
  31. 4.6 Hubei Hengan Fulin Pharmaceutical
  32. 4.6.1 Hubei Hengan Fulin Pharmaceutical Company Information
  33. 4.6.2 Hubei Hengan Fulin Pharmaceutical Business Overview
  34. 4.6.3 Hubei Hengan Fulin Pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hubei Hengan Fulin Pharmaceutical Topical Retinoids Product Portfolio
  36. 4.6.5 Hubei Hengan Fulin Pharmaceutical Recent Developments
  37. 4.7 Heilongjiang Fuhe Pharmaceutical
  38. 4.7.1 Heilongjiang Fuhe Pharmaceutical Company Information
  39. 4.7.2 Heilongjiang Fuhe Pharmaceutical Business Overview
  40. 4.7.3 Heilongjiang Fuhe Pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Heilongjiang Fuhe Pharmaceutical Topical Retinoids Product Portfolio
  42. 4.7.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
  43. 4.8 HEC Pharm
  44. 4.8.1 HEC Pharm Company Information
  45. 4.8.2 HEC Pharm Business Overview
  46. 4.8.3 HEC Pharm Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 HEC Pharm Topical Retinoids Product Portfolio
  48. 4.8.5 HEC Pharm Recent Developments
  49. 4.9 Teva
  50. 4.9.1 Teva Company Information
  51. 4.9.2 Teva Business Overview
  52. 4.9.3 Teva Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Teva Topical Retinoids Product Portfolio
  54. 4.9.5 Teva Recent Developments
  55. 4.10 Taro Pharmaceutical
  56. 4.10.1 Taro Pharmaceutical Company Information
  57. 4.10.2 Taro Pharmaceutical Business Overview
  58. 4.10.3 Taro Pharmaceutical Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Taro Pharmaceutical Topical Retinoids Product Portfolio
  60. 4.10.5 Taro Pharmaceutical Recent Developments
  61. 4.11 Sandoz
  62. 4.11.1 Sandoz Company Information
  63. 4.11.2 Sandoz Business Overview
  64. 4.11.3 Sandoz Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sandoz Topical Retinoids Product Portfolio
  66. 4.11.5 Sandoz Recent Developments
  67. 4.12 Padagis
  68. 4.12.1 Padagis Company Information
  69. 4.12.2 Padagis Business Overview
  70. 4.12.3 Padagis Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Padagis Topical Retinoids Product Portfolio
  72. 4.12.5 Padagis Recent Developments
  73. 4.13 Ligand Pharmaceuticals
  74. 4.13.1 Ligand Pharmaceuticals Company Information
  75. 4.13.2 Ligand Pharmaceuticals Business Overview
  76. 4.13.3 Ligand Pharmaceuticals Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Ligand Pharmaceuticals Topical Retinoids Product Portfolio
  78. 4.13.5 Ligand Pharmaceuticals Recent Developments
  79. 4.14 Hikma
  80. 4.14.1 Hikma Company Information
  81. 4.14.2 Hikma Business Overview
  82. 4.14.3 Hikma Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hikma Topical Retinoids Product Portfolio
  84. 4.14.5 Hikma Recent Developments
  85. 4.15 Galderma Laboratories
  86. 4.15.1 Galderma Laboratories Company Information
  87. 4.15.2 Galderma Laboratories Business Overview
  88. 4.15.3 Galderma Laboratories Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Galderma Laboratories Topical Retinoids Product Portfolio
  90. 4.15.5 Galderma Laboratories Recent Developments
  91. 4.16 Eisai
  92. 4.16.1 Eisai Company Information
  93. 4.16.2 Eisai Business Overview
  94. 4.16.3 Eisai Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Eisai Topical Retinoids Product Portfolio
  96. 4.16.5 Eisai Recent Developments
  97. 4.17 Dr. Reddy's Laboratories
  98. 4.17.1 Dr. Reddy's Laboratories Company Information
  99. 4.17.2 Dr. Reddy's Laboratories Business Overview
  100. 4.17.3 Dr. Reddy's Laboratories Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Dr. Reddy's Laboratories Topical Retinoids Product Portfolio
  102. 4.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 4.18 Bionpharma
  104. 4.18.1 Bionpharma Company Information
  105. 4.18.2 Bionpharma Business Overview
  106. 4.18.3 Bionpharma Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bionpharma Topical Retinoids Product Portfolio
  108. 4.18.5 Bionpharma Recent Developments
  109. 4.19 Bausch Health
  110. 4.19.1 Bausch Health Company Information
  111. 4.19.2 Bausch Health Business Overview
  112. 4.19.3 Bausch Health Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Bausch Health Topical Retinoids Product Portfolio
  114. 4.19.5 Bausch Health Recent Developments
  115. 4.20 Amneal Pharmaceuticals
  116. 4.20.1 Amneal Pharmaceuticals Company Information
  117. 4.20.2 Amneal Pharmaceuticals Business Overview
  118. 4.20.3 Amneal Pharmaceuticals Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Amneal Pharmaceuticals Topical Retinoids Product Portfolio
  120. 4.20.5 Amneal Pharmaceuticals Recent Developments
  121. 4.21 Amdipharm
  122. 4.21.1 Amdipharm Company Information
  123. 4.21.2 Amdipharm Business Overview
  124. 4.21.3 Amdipharm Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Amdipharm Topical Retinoids Product Portfolio
  126. 4.21.5 Amdipharm Recent Developments
  127. 4.22 Allergan
  128. 4.22.1 Allergan Company Information
  129. 4.22.2 Allergan Business Overview
  130. 4.22.3 Allergan Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Allergan Topical Retinoids Product Portfolio
  132. 4.22.5 Allergan Recent Developments
  133. 4.23 Alembic
  134. 4.23.1 Alembic Company Information
  135. 4.23.2 Alembic Business Overview
  136. 4.23.3 Alembic Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Alembic Topical Retinoids Product Portfolio
  138. 4.23.5 Alembic Recent Developments
  139. 4.24 Actavis
  140. 4.24.1 Actavis Company Information
  141. 4.24.2 Actavis Business Overview
  142. 4.24.3 Actavis Topical Retinoids Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Actavis Topical Retinoids Product Portfolio
  144. 4.24.5 Actavis Recent Developments
5 Global Topical Retinoids Market Scenario by Region
  1. 5.1 Global Topical Retinoids Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Topical Retinoids Sales by Region: 2021-2032
  3. 5.2.1 Global Topical Retinoids Sales by Region: 2021-2026
  4. 5.2.2 Global Topical Retinoids Sales by Region: 2027-2032
  5. 5.3 Global Topical Retinoids Revenue by Region: 2021-2032
  6. 5.3.1 Global Topical Retinoids Revenue by Region: 2021-2026
  7. 5.3.2 Global Topical Retinoids Revenue by Region: 2027-2032
  8. 5.4 North America Topical Retinoids Market Facts & Figures by Country
  9. 5.4.1 North America Topical Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Topical Retinoids Sales by Country (2021-2032)
  11. 5.4.3 North America Topical Retinoids Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Topical Retinoids Market Facts & Figures by Country
  16. 5.5.1 Europe Topical Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Topical Retinoids Sales by Country (2021-2032)
  18. 5.5.3 Europe Topical Retinoids Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Topical Retinoids Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Topical Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Topical Retinoids Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Topical Retinoids Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Topical Retinoids Market Facts & Figures by Country
  41. 5.7.1 South America Topical Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Topical Retinoids Sales by Country (2021-2032)
  43. 5.7.3 South America Topical Retinoids Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Topical Retinoids Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Topical Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Topical Retinoids Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Topical Retinoids Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Topical Retinoids Sales by Type (2021-2032)
  2. 6.1.1 Global Topical Retinoids Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Topical Retinoids Sales Market Share by Type (2021-2032)
  4. 6.2 Global Topical Retinoids Revenue by Type (2021-2032)
  5. 6.2.1 Global Topical Retinoids Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Topical Retinoids Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Topical Retinoids Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Topical Retinoids Sales by Application (2021-2032)
  2. 7.1.1 Global Topical Retinoids Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Topical Retinoids Sales Market Share by Application (2021-2032)
  4. 7.2 Global Topical Retinoids Revenue by Application (2021-2032)
  5. 7.2.1 Global Topical Retinoids Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Topical Retinoids Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Topical Retinoids Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Topical Retinoids Value Chain Analysis
  2. 8.1.1 Topical Retinoids Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Topical Retinoids Production Mode & Process
  5. 8.2 Topical Retinoids Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Topical Retinoids Distributors
  8. 8.2.3 Topical Retinoids Customers
9 Global Topical Retinoids Analyzing Market Dynamics
  1. 9.1 Topical Retinoids Industry Trends
  2. 9.2 Topical Retinoids Industry Drivers
  3. 9.3 Topical Retinoids Industry Opportunities and Challenges
  4. 9.4 Topical Retinoids Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst